Showing results (31-40 of 58) with videos related to
Sort By:
Pageof 6
Bioorganic & Medicinal Chemistry Letters|September 11, 2016
Synthesis and P1' SAR exploration of potent macrocyclic tissue factor-factor VIIa inhibitorsVladimir Uladzimir Ladziata, Peter W Glunz, Yan Zou, et al.Stroke|February 8, 2003
Inhibition of factor Xa reduces ischemic brain damage after thromboembolic stroke in ratsXinkang Wang, Lin Xu, Hugh Wang, et al.Bioorganic & Medicinal Chemistry Letters|February 5, 2003
Nonbenzamidine tetrazole derivatives as factor Xa inhibitorsMimi L Quan, Christopher D Ellis, Ming Y He, et al.Bioorganic & Medicinal Chemistry Letters|December 19, 2006
Pyrazole-based factor Xa inhibitors containing N-arylpiperidinyl P4 residuesJennifer X Qiao, Xuhong Cheng, Joanne M Smallheer, et al.Journal of Medicinal Chemistry|October 5, 2007
Discovery of 1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide (apixaban, BMS-562247), a highly potent, selective, efficacious, and orally bioavailable inhibitor of blood coagulation factor XaDonald J P Pinto, Michael J Orwat, Stephanie Koch, et al.ACS Medicinal Chemistry Letters|December 21, 2016
Discovery of Phenylglycine Lactams as Potent Neutral Factor VIIa InhibitorsNicholas R Wurtz, Brandon L Parkhurst, Wen Jiang, et al.Bioorganic & Medicinal Chemistry Letters|February 19, 2013
Design and synthesis of bicyclic pyrazinone and pyrimidinone amides as potent TF-FVIIa inhibitorsXiaojun Zhang, Peter W Glunz, Wen Jiang, et al.Bioorganic & Medicinal Chemistry Letters|May 3, 2017
Neutral macrocyclic factor VIIa inhibitorsNicholas R Wurtz, Brandon L Parkhurst, Indawati DeLucca, et al.Bioorganic & Medicinal Chemistry Letters|July 13, 2013
Nonbenzamidine acylsulfonamide tissue factor-factor VIIa inhibitorsPeter W Glunz, Xiaojun Zhang, Yan Zou, et al.Journal of Medicinal Chemistry|March 18, 2005
Discovery of 1-(3'-aminobenzisoxazol-5'-yl)-3-trifluoromethyl-N-[2-fluoro-4- [(2'-dimethylaminomethyl)imidazol-1-yl]phenyl]-1H-pyrazole-5-carboxyamide hydrochloride (razaxaban), a highly potent, selective, and orally bioavailable factor Xa inhibitorMimi L Quan, Patrick Y S Lam, Qi Han, et al.Pageof 6